Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
暂无分享,去创建一个
J. Gómez-Reino | L. Carmona | E. Mola | Juan J Gómez-Reino | Loreto Carmona | Vicente Rodríguez Valverde | Emilio Martín Mola | Maria Dolores Montero | M. Montero | V. Valverde
[1] R. Cooper,et al. Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis. , 2001, Rheumatology.
[2] P. Small,et al. Management of tuberculosis in the United States. , 2001, The New England journal of medicine.
[3] E. Chiner,et al. [Tuberculosis notification from 1987 to 1999 for the public health area of the community of Valencia (Spain)]. , 2001, Archivos de bronconeumologia.
[4] R N Maini,et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.
[5] E. Karlson,et al. Experience with etanercept in an academic medical center: are infection rates increased? , 2002, Arthritis and rheumatism.
[6] P. Lipsky,et al. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial , 1999, The Lancet.
[7] P. Taylor,et al. Anti–tumor necrosis factor therapies , 2001, Current opinion in rheumatology.
[8] E. Chiner,et al. Evolución de la declaración de la tuberculosis en un área sanitaria de la Comunidad Valenciana desde 1987 hasta 1999 , 2001 .
[9] E. Díaz-Jouanen,et al. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. , 1999, Clinical and experimental rheumatology.
[10] Joseph Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .